BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25922067)

  • 1. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
    Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
    J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
    Collins PE; Kiely PA; Carmody RJ
    J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
    Kohda A; Yamazaki S; Sumimoto H
    J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
    Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
    Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.
    Wu CL; Kandarian SC; Jackman RW
    PLoS One; 2011 Jan; 6(1):e16171. PubMed ID: 21249144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.
    Wessells J; Baer M; Young HA; Claudio E; Brown K; Siebenlist U; Johnson PF
    J Biol Chem; 2004 Nov; 279(48):49995-50003. PubMed ID: 15465827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
    Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T
    J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
    Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D
    Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
    Mathas S; Jöhrens K; Joos S; Lietz A; Hummel F; Janz M; Jundt F; Anagnostopoulos I; Bommert K; Lichter P; Stein H; Scheidereit C; Dörken B
    Blood; 2005 Dec; 106(13):4287-93. PubMed ID: 16123212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3.
    Dai R; Phillips RA; Ahmed SA
    J Immunol; 2007 Aug; 179(3):1776-83. PubMed ID: 17641044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.
    Li Z; Nabel GJ
    Mol Cell Biol; 1997 Oct; 17(10):6184-90. PubMed ID: 9315679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
    Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
    Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.
    Latimer M; Ernst MK; Dunn LL; Drutskaya M; Rice NR
    Mol Cell Biol; 1998 May; 18(5):2640-9. PubMed ID: 9566883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.
    Dooher JE; Paz-Priel I; Houng S; Baldwin AS; Friedman AD
    Mol Cancer Res; 2011 Oct; 9(10):1395-405. PubMed ID: 21813505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.
    Reißig S; Tang Y; Nikolaev A; Gerlach K; Wolf C; Davari K; Gallus C; Masri J; Mufazalov IA; Neurath MF; Wunderlich FT; Schattenberg JM; Galle PR; Weigmann B; Waisman A; Glasmacher E; Hövelmeyer N
    Nat Commun; 2017 Apr; 8():15069. PubMed ID: 28452361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
    Keutgens A; Zhang X; Shostak K; Robert I; Olivier S; Vanderplasschen A; Chapelle JP; Viatour P; Merville MP; Bex F; Gothot A; Chariot A
    J Biol Chem; 2010 Aug; 285(33):25831-40. PubMed ID: 20558726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.